Results
738
Analysts expect these companies to experience strong growth in earnings over the next 3 years. They also meet criteria around being in an acceptable financial position.
738 companies
GE Vernova T&D India
Market Cap: ₹764.0b
Engages in building power transmission and distribution infrastructure in India and internationally.
522275
₹2,983.90
7D
8.8%
1Y
86.1%
Acutaas Chemicals
Market Cap: ₹120.4b
Engages in the research and development, manufacture, and sale of pharmaceutical intermediates in India and internationally.
ACUTAAS
₹1,471.00
7D
-0.1%
1Y
91.4%
Asia Vital Components
Market Cap: NT$409.5b
Provides thermal solutions worldwide.
3017
NT$1,055.00
7D
2.9%
1Y
88.1%
Sichuan Huafeng Technology
Market Cap: CN¥49.0b
Engages in the research, development, manufacture, and sale of optical and electrical connectors and cable assemblies in China.
688629
CN¥106.21
7D
29.0%
1Y
503.1%
ASPEED Technology
Market Cap: NT$195.0b
Operates as a fabless integrated circuit (IC) design company in Taiwan, China, the United States, and internationally.
5274
NT$5,155.00
7D
3.5%
1Y
18.8%
Pantoro Gold
Market Cap: AU$2.1b
Engages in the gold mining, processing, and exploration activities in Western Australia.
PNR
AU$5.35
7D
3.5%
1Y
162.3%
Zhejiang China Commodities City Group
Market Cap: CN¥105.2b
Through its subsidiaries, develops, manages, and operates an online trading platform service in China.
600415
CN¥19.19
7D
-4.8%
1Y
123.4%
Ruijie Networks
Market Cap: CN¥73.9b
Engages in the research and development, design, and sales of network equipment, network security products, and cloud desktop solutions in China and internationally.
301165
CN¥92.86
7D
3.6%
1Y
321.5%
Trent
Market Cap: ₹1.8t
Engages in the retailing and trading of apparels, footwear, accessories, food, grocery, and non-food products in India.
500251
₹5,144.50
7D
-0.5%
1Y
-29.8%
Shanghai Chicmax Cosmetic
Market Cap: HK$40.5b
A multi-brand cosmetics company, engages in the research, development, manufacture, and sale of cosmetics products in Mainland China and internationally.
2145
HK$101.80
7D
7.0%
1Y
220.1%
Lhyfe
Market Cap: €139.1m
Produces and supplies renewable green hydrogen for mobility and industry markets.
LHYFE
€2.96
7D
0.2%
1Y
-20.1%
Capricor Therapeutics
Market Cap: US$284.4m
A clinical-stage biotechnology company, engages in the development of transformative cell and exosome-based therapeutics for treating duchenne muscular dystrophy (DMD) and other diseases with unmet medical needs in the United States.
CAPR
US$6.08
7D
-3.9%
1Y
18.8%
Soleno Therapeutics
Market Cap: US$2.6b
A clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases.
SLNO
US$50.98
7D
-15.1%
1Y
-4.8%
Renasant
Market Cap: US$3.6b
Operates as a bank holding company for Renasant Bank that provides a range of financial, wealth management, fiduciary, and insurance services to retail and commercial customers.
RNST
US$37.74
7D
-2.3%
1Y
13.0%
Achieve Life Sciences
Market Cap: US$157.4m
A late-stage pharmaceutical company, develops and commercializes cytisinicline for nicotine independence in Canada, the United States, and the United Kingdom.
ACHV
US$2.96
7D
-9.8%
1Y
-32.7%
BRP
Market Cap: CA$6.5b
Designs, develops, manufactures, and sells powersports vehicles and marine products in the Mexico, Canada, Austria, the United States, Finland, Australia, and Germany.
DOO
CA$88.10
7D
-1.2%
1Y
6.2%
RenovoRx
Market Cap: US$46.2m
A clinical-stage biopharmaceutical company, engages in the developing of targeted combination therapies to enhance therapeutic outcomes for cancer patients undergoing treatment.
RNXT
US$1.22
7D
4.3%
1Y
23.2%
Excelerate Energy
Market Cap: US$2.7b
Provides liquefied natural gas (LNG) solutions worldwide.
EE
US$23.99
7D
1.1%
1Y
16.0%
Abeona Therapeutics
Market Cap: US$291.3m
A clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases.
ABEO
US$5.64
7D
-13.6%
1Y
3.5%
OS Therapies
Market Cap: US$70.3m
A clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States.
OSTX
US$2.20
7D
0%
1Y
-37.5%
Tenaya Therapeutics
Market Cap: US$205.3m
A clinical-stage biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States.
TNYA
US$1.22
7D
-6.2%
1Y
-39.6%
Madrigal Pharmaceuticals
Market Cap: US$9.5b
A biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States.
MDGL
US$417.43
7D
-2.9%
1Y
79.0%
Ares Management
Market Cap: US$58.4b
Operates as an alternative asset manager in the United States, Europe, and Asia.
ARES
US$178.89
7D
-0.02%
1Y
17.4%
Enterprise Group
Market Cap: CA$110.8m
Through its subsidiaries, operates as an equipment rental and construction services company in Canada.
E
CA$1.44
7D
5.9%
1Y
-20.9%
Cingulate
Market Cap: US$20.7m
A biopharmaceutical company, develops pharmaceutical products using delivery platform technology for the treatment of attention deficit/hyperactivity disorder (ADHD) and anxiety in the United States.
CING
US$3.70
7D
-3.6%
1Y
-25.1%
ARS Pharmaceuticals
Market Cap: US$930.0m
A biopharmaceutical company, develops and commercializes treatments for severe allergic reactions.
SPRY
US$9.57
7D
-8.9%
1Y
-31.9%
Aldeyra Therapeutics
Market Cap: US$297.8m
A biotechnology company, discovers and develops therapies designed to treat immune-mediated and metabolic diseases.
ALDX
US$4.90
7D
-11.6%
1Y
-16.5%
Ryan Specialty Holdings
Market Cap: US$13.9b
Operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, rest of Europe, India, and Singapore.
RYAN
US$53.40
7D
4.7%
1Y
-15.0%
LENZ Therapeutics
Market Cap: US$1.2b
Operates as a biopharmaceutical company that focuses on the development and commercialization of therapies to improve vision in the United States.
LENZ
US$42.23
7D
1.2%
1Y
96.4%
Beyond Air
Market Cap: US$12.6m
A commercial-stage medical device and biopharmaceutical company, develops the Lungfit platform, a nitric oxide (NO) generator and delivery system platform.
XAIR
US$2.28
7D
0.9%
1Y
-71.5%
Bank of Marin Bancorp
Market Cap: US$389.1m
Operates as the holding company for Bank of Marin that provides a range of financial services to small to medium-sized businesses, not-for-profit organizations, and commercial real estate investors in the United States.
BMRC
US$24.48
7D
-1.2%
1Y
19.9%
Vertiv Holdings Co
Market Cap: US$52.2b
Designs, manufactures, and services critical digital infrastructure technologies and life cycle services for data centers, communication networks, and commercial and industrial environments in the Americas, the Asia Pacific, Europe, the Middle East, and Africa.
VRT
US$136.83
7D
0.07%
1Y
56.1%
MP Materials
Market Cap: US$11.7b
Produces rare earth materials in the Western Hemisphere.
MP
US$66.81
7D
7.0%
1Y
373.2%
Circle Internet Group
Market Cap: US$31.2b
Operates as a platform, network, and market infrastructure for stablecoin and blockchain applications.
CRCL
US$131.04
7D
15.3%
1Y
n/a
Spotify Technology
Market Cap: US$144.9b
Provides audio streaming subscription services worldwide.
SPOT
US$707.19
7D
0.4%
1Y
105.6%
Pagaya Technologies
Market Cap: US$3.2b
A product-focused technology company, deploys data science and proprietary artificial intelligence-powered technology for financial services and other service providers, their customers, and asset investors in the United States, Israel, and the Cayman Islands.
PGY
US$41.95
7D
13.7%
1Y
238.0%